Myofibroblast involvement in renal interstitial fibrosis

Nephrology

Volumn 2, Issue 4, 1996, Pages 229-234

  Hewitson, Tim ^a   Becker, Gavin ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Fibroblast; Fibrogenesis; Interstitium

Indexed keywords

EID: 0000166998     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1996.tb00092.x     Document Type: Article

References (81)

1. Kuncio GS, Neilson EG, Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int. 1991; 39: 550-6.
2. Risdon RA, Sloper JC, Wardener HE de. Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968; I: 363-6.
3. Schainuck LI, Striker GE, Cutler RE, Benditt EP. Structural-functional correlations in renal disease: Part II. The correlations. Hum. Pathol. 1970; 1: 631-41.
4. Cameron JS. Tubular and interstitial factors in the progression of glomerulonephritis. Pediatr. Nephrol. 1992; 6: 292-303.
5. Mackensen-Haen S, Bader R, Grund KE, Bohle A. Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin. Nephrol. 1981; 15: 167-71.
6. Mackensen S, Grund KE, Sindjic M, Bohle A. Influence of the renal cortical interstitium on the serum creatinine concentration and serum creatinine clearance in different chronic sclerosing interstitial nephritides. Nephron. 1979; 24: 30-4.
7. Bohle A, Wehrmann M, Bogenschutz O et al. The long-term prognosis of the primary glomerulonephritides. Pathol. Res. Pract. 1992; 188: 908-24.
8. Gonzalez-Avila G, Vadillo-Ortega F, Perez-Taamayo R. Experimental diffuse interstitial fibrosis: A biochemical approach. Lab. Invest. 1988; 59: 245-52.
9. Jones CL. Matrix degradation in renal disease. Nephrology 1996; 2: 13-23.
10. Scheinman JI, Tanaka H, Haralson M, Wang S, Brown O. Specialized collagen mRNA and secreted collagens in human glomerular epithelial, mesangial, and tubular cells. J. Am. Soc. Nephrol. 1992; 2: 1475-83.
11. Müller GA, Markovic-Lipkovski J, Frank J, Rodemann HP. The role of interstitial cells in the progression of renal diseases. J. Am. Soc. Nephrol. 1992; 2, Supp. 2: S198-205.
12. Hewitson TD, Wu H, Becker GJ. Interstitial myofibroblasts in experimental renal infection and scarring. Am. J. Nephrol. 1995; 15: 411-17.
13. Trelstad RL, Birk DE. The fibroblast in morphogenesis and fibrosis: cell topography and surface-related functions. CIBA Found. Symp. 1985; 114: 4-19.
14. Strutz F. Novel aspects of renal fibrogenesis. Nephrol. Dial. Transplant. 1995; 10: 1526-32.
15. Tisher CC, Madsen KM, Anatomy of the Renal Interstitium; Davison AM (eds). Nephrology 2nd edn. Bailliere Tindall, London, 1988; 587-98.
16. Takahashi-Iwanaga H. The three-dimensional cytoarchitecture of the interstitial tissue in the rat kidney. Cell Tissue Res. 1994; 264: 269-81.
17. Sappino A, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as a marker of phenotypic modulations. Lab. Invest. 1990; 63: 144-61.
18. Gabbiani G, Ryan GB, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971; 27: 549-50.
19. Alpers CE, Hudkins KL, Floege J, Johnson RJ. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J. Am. Soc. Nephrol. 1994; 5: 201-10.
20. Goumenos DS, Brown CB, Shortland J, El Nahas AM. Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol. Dial. Transplant. 1994; 9: 1418-25.
21. Hewitson TD, Becker GJ. Interstitial myofibroblasts in IgA glomerulonephritis. Am. J. Nephrol. 1995; 15: 111-17.
22. Diamond JR, Van Goor H, Ding G, Engelmyer E. Myofibroblasts in experimental hydronephrosis. Am. J. Pathol. 1995; 146: 121-9.
23. Eyden BP. Brief review of the fibronexus and its significance for myofibroblastic differentiation and tumour diagnosis. Ultrastruct. Pathol. 1993; 17: 611-22.
24. Jimenez SA, Martinez A, Fibroblasts. Roitt IM, Delves PJ (eds). Encyclopedia of Immunology. Academic Press, London 1992; 562-7.
25. Ross R, Everett NB, Tyler R. Wound healing and collagen formation. VI. The origin of the wound. Fibroblast studied in parabiosis. J. Cell Biol. 1970; 44: 645-54.
26. Wiggins R, Goyal M, Merritt S, Killen PD. Vascular adventitial cell expression of collagen I messenger ribonucleic acid in antiglomerular basement membrane antibody induced crescentic nephritis in the rabbit. A cellular source for interstitial collagen synthesis in inflammatory renal disease. Lab. Invest. 1993; 68: 557-65.
27. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Molecular Medicine 1994; 1: 71-81.
28. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Neilson EG. Identification and characterisation of a fibroblast marker-FSP1. J. Cell Biol 1995; 130: 393-405.
29. Strutz F. The fibroblast - a (trans-) differentiated cell? Nephrol. Dial. Transplant. 1995; 10: 1504-6.
30. Clark RAF. Wound repair. Curr. Opin. Cell Biol. 1989; 1: 1000-8.
31. Ronnov-Jessen L, Petersen OW. Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Lab. Invest. 1993; 68: 696-707.
32. Bayreuther K, Francz PI, Gogol J, Hapke C, Maier M, Meinrath HG. Differentiation of primary and secondary fibroblasts in cell culture systems. Mutation Research 1991; 1991: 233-42.
33. Nehls V, Drenckhahn D. The versatility of microvascular pericytes: from mesenchyme to smooth muscle? Histochemistry. 1993; 99: 1-12.
34. Bhawan J, Majno G. The myofibroblast. Possible derivation from macrophages in xanthogranuloma. Am. J. Dermatopathol. 1989; 11: 255-8.
35. Hines JE, Johnson SJ, Burt AD. In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. Am. J. Pathol. 1993; 142: 511-18.
36. Hosenpud JD. Immune mechanisms of cardiac allograft vasculopathy: An update. Transplant. Immunol. 1993; 1: 237-49.
37. Desmouliere A, Gabbiani G. The cytoskeleton of arterial smooth muscle cells during human and experimental atheromatosis. Kidney Int. 1992; 41 (Suppl. 37): S87-9.
38. Kovacs EJ, DiPietro LA. Fibrogenic cytokines and connective tissue production. FASEB J. 1994; 8: 854-61.
39. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. 1995;
40. Rodemann HP, Müller GA. Abnormal growth and clonal proliferation of fibroblasts derived from kidneys with intersititial fibrosis. Proc. Soc. Exp. Biol. Med. 1990; 195: 57-63.
41. Noronha IL, Niemir Z, Stein H, Waldherr R. Cytokines and growth factors in renal disease. Nephrol. Dial. Transplant. 1995; 10: 775-86.
42. Goyal M, Wiggins R. Fibronectin mRNA and protein accumulation, distribution and breakdown in rabbit antiglomerular basement membrane disease. J. Am. Soc. Nephrol. 1991; 1: 1334-41.
43. Hynes RO, Yamada KM. Fibronectins: multifunctional modular glycoproteins. J. Cell Biol. 1982; 95: 369-77.
44. Rodemann HP, Müller GA. Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. Am. J. Kidney Dis. 1991; 17: 684-86.
45. David G, Lories V, Heremans A, Van Der Schueren B, Cassiman J, Van Der Berghe H. Membrane-associated chrondroitin sulfate proteoglycans of human lung fibroblasts. J. Cell Biol. 1989; 108: 1165-75.
46. Heldin P, Laurent TC, Heldin C. Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem. J. 1989; 258: 919-22.
47. Valle K, Bauer EA. Biosynthesis of collagenase by human skin fibroblasts in monolayer culture. J. Bio. Chem. 1979; 254: 10115-22.
48. Bachmann S, Le Hir M, Eckardt K. Co-localization of erythropoietin mRNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J. Histochem. Cytochem. 1993; 41: 335-41.
49. Korn JH. Substrain heterogeneity in prostaglandin E2 synthesis of human dermal fibroblasts. Arthritis Rheum. 1985; 28: 315-22.
50. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today. 1995; 16: 21-6.
51. Strutz F, Müller GA. On the progression of chronic renal disease. Nephron 1995; 69: 371-9.
52. Nouwen EJ, DeBroe ME. EGF and TGF-alpha in the human kidney- identification of octopal cells in the collecting duct. Kidney Int. 1994; 45: 1510-21.
53. Fine LG, Hammerman MR, Abboud HE. Evolving role of growth factors in the renal response to acute and chronic disease. J. Am. Soc. Nephrol. 1992; 2: 1163-70.
54. Johnson RJ, Floege J, Couser WG, Alpers CE. Role of platelet-derived growth factor in glomerular disease. J. Am. Soc. Nephrol. 1993; 4: 119-28.
55. Knecht A, Fine LG, Kleinman KS. Fibroblasts of the rabbit kidney in culture: II. Paracrine stimulation of papillary fibroblasts by PDGF. Am. J. Physiol. 1991; 261: F292-9.
56. Schmitt-Graff A, Desmouliere A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch. 1994; 425: 3-24.
57. Ichimura T, Maier JAM, Maciag T, Zhang GH, Stevens JL. FGF-1 in normal and regenerating kidney- expression in mononuclear, interstitial, and regenerating epithelial cells. Am. J. Physiol. 1995; 269: F653-62.
58. Alvarez RJ, Sun MJ, Haverty TP, Iozzo RV, Myers JC, Neilson EG. Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int. 1992; 41: 14-23.
59. Alpers CE, Seifert RA, Hudkins KL, Johnson RJ, Bowen-Pope DF. PDGF-receptor localizes to mesangial, parietal epithelial and interstitial cells in human and primate kidneys. Kidney Int. 1993; 43: 286-94.
60. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor beta-1 induces alpha smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 1993; 123: 104-11.
61. Tang WW, Ulich TR, Lacey DL et al. Platelet derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am. J. Pathol. 1996; 148: 1169-80.
62. Shimokado K, Raines EW, Madtes DK, Barrett TB. A significant part of macrophage derived growth factor consists of at least 2 forms of PDGF. Cell 1985; 43: 277-86.
63. Baird A, Mormede P, Bohlen P. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage derived growth factor. Biochem. Biophys. Res. Commun. 1985; 126: 358-64.
64. Associan RK, Fleurdelys BE, Stevenson HC et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc. Natl Acad. Sci. USA 1987; 84: 6020-4.
65. Kaneto H, Morrissey J, McCracken R, Ishidoya S, Reyes AA, Klahr S. The expression of mRNA for tumor necrosis factor alpha increases in the obstructed kidney of rats soon after unilateral ureteral ligation. Nephrology 1996; 2: 161-6.
66. Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int. 1993; 44: 643-53.
67. Larjava H, Sandberg M, Happonen R, Vuorio E. Differential localization of type I and type III procollagen messenger ribonucleic acids in inflamed periodontal and periapical connective tissues by in situ hybridization. Lab. Invest. 1990; 62: 96-103.
68. Hewitson TD, Smith KGC, Becker GJ. Apoptosis and resolution of experimental renal infective tubulointerstitial nephritis. Nephrology 1996; 2: 127-32.
69. Darby I, Skalli O, Gabbiani G. α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Invest. 1990; 63: 21-9.
70. Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 1995; 146: 56-66.
71. Arends MJ, Morris RG, Wyllie AH. Apoptosis; the role of endonuclease. Am. J. Pathol. 1990; 136: 593-608.
72. Ueda N, Shah N. Apoptosis. J. Lab. Clin. Med. 1994; 124: 169-77.
73. Savill J. Apoptosis and the kidney. J. Am. Soc. Nephrol. 1994; 5: 12-21.
74. Kon K, Fujiwara T. Transformation of fibroblasts into endothelial cells during angiogenesis. Cell Tissue Res. 1994; 278: 625-8.
75. Vangelisra A, Frasca GM, Severi B, Bonomini V. The role of myofibroblasts in renal interstitial fibrosis and their relationship with fibronectin and type IV collagen. Contrib. Nephrol. 1989; 70: 135-41.
76. Kriz W, Elger M, Lemley K, Sakai T. Structure of the glomerular mesangium: a biomechanical interpretation. Kidney Int. 1990; 38 (Suppl. 30): S2-9.
77. Johnson RJ, Lida H, Alpers CE et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J. Clin. Invest. 1991; 87: 847-58.
78. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE. The activated mesangial cell: a glomerular myofibroblast? J. Am. Soc. Nephrol. 1992; 2: S190-7.
79. Lewis MP, Fine LG, Norman JT. Pexicrine effects of basement membrane components on paracrine signaling by renal tubular cells. Kidney Int. 1996; 49: 48-58.
80. Nakajima M, Hewitson TD, Mathews DC, Kincaid-Smith PS. Platelet-derived growth factor mesangial deposits in mesangial IgA glomerulonephritis. Nephrol. Dial. Transplant. 1991; 6: 11-16.
81. Yoshimura A, Gordon K, Alpers CE et al. Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int. 1991; 40: 470-6.